GlassScriptPhysician profile
Heather Turner
NPI 1518508142
$1,573.47
in general payments reported to CMS, 2019-2025
20 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.47 · 2022: $484 · 2023: $279 · 2024: $359 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,015.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $253.52 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $241.86 | 2023-2025 | |
| Novo Nordisk INC | $230.40 | 2022 | |
| Axsome Therapeutics, INC. | $216.44 | 2024-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $78.08 | 2021-2023 | Rexulti |
| Gilead Sciences, INC. | $71.07 | 2023-2024 | Epclusa |
| Biohaven Pharmaceutical Holding Company LTD. | $62.66 | 2022 | |
| Alkermes, INC. | $55.14 | 2022-2023 | Aristada, Lybalvi |
| Coopersurgical, INC. | $42.18 | 2022-2023 | Paragard T 380a |
| Indivior INC. | $37.48 | 2024 | Sublocade |
| Lilly USA, LLC | $36.13 | 2021-2022 | |
| Pfizer INC. | $33.98 | 2024-2025 | |
| Organon LLC | $33.03 | 2022-2025 | Nuvaring, Nexplanon |
| Braeburn INC. | $32.39 | 2025 | Brixadi |
| Janssen Pharmaceuticals, INC | $29.73 | 2025 | Spravato |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $28.92 | 2025 | Restrata Wound Matrix |
| Astrazeneca Pharmaceuticals LP | $26.98 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.03 | 2024 | Caplyta |
| Corium, LLC | $21.38 | 2022-2023 | Azstarys |
| Viiv Healthcare Company | $19.07 | 2023 | Apretude |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.